Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Pralatrexate

EU orphan designation number: EU/3/07/444   
Active ingredient: Pralatrexate
Indication: Treatment of peripheral T-cell lymphoma (nodal, other extranodal and leukaemic/disseminated)
Sponsor: Allos Therapeutics Limited
71 Knowl Piece, Wilbury Way, Hitchin, Hertfordshire SG4 0TY, United Kingdom

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
17/04/2007 Centralised Orphan - Designation EMEA/OD/100/06 (2007)1773 of 13/04/2007
06/12/2007 Centralised Orphan - Transfer of orphan designation EMEA/OD/100/06/T/01 (2007)6135 of 04/12/2007
19/04/2010 Centralised Orphan - Transfer of orphan designation EMEA/OD/100/06/T/02 (2010)2504 of 15/04/2010
18/08/2010 Other procedure EMA/408875/2010